ObsEva (OBSV) News Today

$0.05

0.00 (0.00%)

(As of 11/24/2023)

Compare

Today's Range: $0.05
▼
$0.05
50-Day Range: $0.04
▼
$0.09
52-Week Range: $0.08
▼
$2.14

Volume: 17 shs
Average Volume: 8.94 million shs
Market Capitalization: $3.90 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Competitors Earnings Financials Headlines Ownership SEC Filings Social Media

Source

Source	Headline
	StockNews.com Initiates Coverage on ObsEva (NASDAQ:OBSV) americanbankingnews.com - November 28 at 1:30 AM
	ObsEva (NASDAQ:OBSV) Now Covered by StockNews.com americanbankingnews.com - November 20 at 3:30 AM
	ObsEva SA OBSN morningstar.com - November 11 at 10:37 PM
	ObsEva SA OBSEF morningstar.com - November 11 at 7:36 AM
	ObsEva (NASDAQ: OBSV) fool.com - June 18 at 11:34 PM
	ObsEva Files Year End 2022 Financial Statements finance.yahoo.com - March 31 at 5:48 PM
	ObsEva Announces Progress Towards its Plans to Consolidate Operations in Switzerland: Delisting of OBSV from The Nasdaq Stock Market effective March 23, 2023 finance.yahoo.com - March 15 at 5:57 AM
	ObsEva Names Fabien De Ladonchamps CEO, Ernest Loumaye Interim Chairman markets.businessinsider.com - March 13 at 4:46 PM
	ObsEva Announces Update Towards its Strategic Reorganization to Consolidate Operations in Switzerland finance.yahoo.com - March 13 at 7:04 AM
	Why Puma Biotechnology Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session benzinga.com - March 3 at 2:19 PM
	Why Is ObsEva (OBSV) Stock Up 93% Today? investorplace.com - March 3 at 9:21 AM
	Why ObsEva (OBSV) Stock Is Down 36% Today investorplace.com - February 24 at 11:16 AM
	ObsEva Announces Strategic Reorganization to Consolidate Operations in Switzerland finance.yahoo.com - February 24 at 3:11 AM
	ObsEva Evidences Compliance with Nasdaq’s Stockholder’s Equity Rule and Announces Moratorium Dismissal Request Filing uk.finance.yahoo.com - January 12 at 1:02 PM
	ObsEva Announces Dismissal of Moratorium Proceedings finance.yahoo.com - December 19 at 7:58 AM
	ObsEva Evidences Compliance with Nasdaq’s Stockholder’s Equity Rule and Announces Moratorium Dismissal Request Filing finance.yahoo.com - December 14 at 4:00 AM
	ObsEva SA (OBSV) Reports Q3 Loss, Lags Revenue Estimates finance.yahoo.com - December 1 at 9:11 PM
	ObsEva Announces Third Quarter 2022 Financial Results and Provides a Business Update finance.yahoo.com - December 1 at 4:10 PM
	ObsEva Announces Progress on Cost Reduction Initiatives and Stay of Moratorium Proceedings finance.yahoo.com - October 27 at 12:52 AM
	ObsEva SA (OBSV) finance.yahoo.com - October 16 at 6:41 PM
	ObsEva : China Approves Yuyuan Bioscience's IND Application For Phase 1 Trial Of Nolasiban markets.businessinsider.com - October 14 at 10:02 AM
	ObsEva Announces IND Approval for Yuyuan Bioscience’s Phase 1 Clinical Trial of Nolasiban in China - Yahoo Finance finance.yahoo.com - October 13 at 1:31 PM
	ObsEva Says Partner Yuyuan Bioscience Obtained Regulatory Nod for Nolasiban Drug Trial in China - Marketscreener.com marketscreener.com - October 13 at 8:31 AM
	ObsEva Announces IND Approval for Yuyuan Bioscience's Phase 1 Clinical Trial of Nolasiban in China - ObsE - Benzinga benzinga.com - October 13 at 8:31 AM
	ObsEva's Chinese Partner Wins Regulatory Nod To Launch Early-stage Trial Of Clinical Pregnancy Drug - Marketscreener.com marketscreener.com - October 13 at 1:49 AM
	ObsEva Announces IND Approval for Yuyuan Bioscience's Phase - GlobeNewswire globenewswire.com - October 13 at 1:49 AM
	ObsEva Announces IND Approval for Yuyuan Bioscience’s Phase 1 Clinical Trial of Nolasiban in China finance.yahoo.com - October 13 at 1:49 AM
	OBSV.PH - Obseva SA \| Stock Price & Latest News \| Reuters reuters.com - October 6 at 8:07 AM
	ObsEva Flat on Restructuring Initiatives - Baystreet.ca baystreet.ca - September 15 at 5:16 AM
	After FDA Regulatory Setback, Penny Stock ObsEva Cuts 70% Of Its Staff finance.yahoo.com - September 13 at 1:11 PM
	ObsEva Announces Progress on Restructuring Initiatives - GlobeNewswire globenewswire.com - September 13 at 3:10 AM
	OBSV.O - Obseva SA \| Stock Price & Latest News \| Reuters reuters.com - September 11 at 10:33 AM
	OBSV.N - Obseva SA \| Stock Price & Latest News \| Reuters reuters.com - September 10 at 8:40 AM
	This Women Health Stock Gets Analyst Downgrade On 'Approvability Issues, Restructuring' finance.yahoo.com - September 7 at 5:20 AM
	Hot Penny Stocks For Your Buy List in September? 3 to Watch - StreetInsider.com streetinsider.com - August 31 at 8:57 PM
	Bluebird bio Seeks Back-to-Back Nods, 'Go' or 'No-Go' For Revance's Botox Rival, Amylyx' Twin Hurdles And More: September's Key PDUFA Catalysts Biotech Investors Must Know By Benzinga - Investing.com UK uk.investing.com - August 31 at 8:57 PM
	Global Female Infertility Drug Pipeline Market Report 2022: Insights about 12 Pipelines Drugs Including Emerging Drugs - OXO-001 (Oxolife) & Nolasiban (ObsEva) - ResearchAndMarkets.com - Business Wire businesswire.com - August 25 at 7:08 AM
	ObsEva stock dips on Nasdaq non-compliance notice - Seeking Alpha seekingalpha.com - August 23 at 5:48 AM
	ObsEva Receives Nasdaq Non-Compliance Notice - GlobeNewswire globenewswire.com - August 22 at 4:45 AM
	ObsEva Receives Nasdaq Non-Compliance Notice finance.yahoo.com - August 22 at 4:45 AM
	OBSEVA : INDEX TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Form 6-K - Marketscreener.com marketscreener.com - August 19 at 10:34 AM
	ObsEva: Q2 Earnings Insights - Benzinga benzinga.com - August 18 at 3:14 PM
	ObsEva Files Second Quarter 2022 Financial Statements - GlobeNewswire globenewswire.com - August 17 at 6:33 PM
	ObsEva Files Second Quarter 2022 Financial Statements finance.yahoo.com - August 17 at 6:33 PM
	Kissei Pharmaceutical : Supplementary Explanatory Materials on Financial Results for the Three Months ended June 30, 2022 - Marketscreener.com marketscreener.com - August 5 at 5:37 AM
	All You Need to Know About ObsEva SA (OBSV) Rating Upgrade to Buy - Nasdaq nasdaq.com - August 3 at 6:29 PM
	All You Need to Know About ObsEva SA (OBSV) Rating Upgrade to Buy finance.yahoo.com - August 3 at 6:29 PM
	ObsEva SA Tops Q2 EPS by 5c By Investing.com - Investing.com investing.com - August 2 at 3:36 PM
	ObsEva SA Tops Q2 EPS by 5c By Investing.com - Investing.com Canada ca.investing.com - August 2 at 10:03 AM
	ObsEva Announces $31 million Debt Retirement and $11 million Debt Refinancing - StreetInsider.com streetinsider.com - August 2 at 12:52 AM

Get ObsEva News Delivered to You Automatically

OBSV Media Mentions By Week

OBSV Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

OBSV
News Sentiment
▼
0.00

0.76
▲
Average
Medical
News Sentiment

OBSV News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

OBSV Articles
This Week
▼
1

0
▲
OBSV Articles
Average Week

Get ObsEva News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:OBSV) was last updated on 11/28/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

ObsEva (OBSV) News Today

OBSV Media Mentions By Week

OBSV Media Sentiment

OBSV News Coverage

Related Companies and Tools

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info